Le Lézard
Classified in: Health
Subject: SVY

Two Day Interactive Course: Effective Training Skills and Processes in the Pharma Industry - London, United Kingdom - October 22-23, 2019


DUBLIN, Sept. 19, 2019 /PRNewswire/ -- The "Effective Training Skills and Processes in the Pharma Industry" conference has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Interactive course ideal for anyone with responsibility for planning or delivering training in the Pharma, Device or Animal Health Industries (including GXP and SOP training to comply with EU and FDA inspection requirements).

Course Overview

Training can play an important role in the success of a company and in employee performance, with effective training and support helping with higher productivity and resulting in lower staff turnover. There is also increasing scrutiny by regulatory inspectors to assess compliance of training and related documentation. Lack of or inadequate, formal processes and procedures for training and poor training documentation are among the top inspection findings.

This intensive two-day course will enable you to understand how to train others effectively through interactive discussions, exercises, and practical examples. Using a proven and best practice framework for training, this programme will equip you with greater confidence, skills, techniques, and knowledge to design, deliver, evaluate and identify training needs and implement a successful training strategy in your role, as well as ensuring regulatory compliance.

Benefits of attending:

Who Should Attend:

This course is designed for all those who have responsibilities for planning, organising or delivering training within the pharmaceutical, biopharmaceutical, device or animal health industries. It will be ideal for those who need to carry out some training as part of their role, those new to a training role, and those who may wish to refresh and develop their existing skills.

Agenda:

Maximise the effectiveness of your training

Training needs analysis, developing a training strategy and training plans for compliance in the pharma industry

Tools for planning and designing training

Delivering training to high standards, including using the latest technology

Interactive sessions for technical and SOP training

Evaluation of training

For more information about this conference visit https://www.researchandmarkets.com/r/kpx1jo

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...



News published on and distributed by: